Roarlix 120mg Tablet

About

Roarlix 120mg Tablet is a novel antithrombotic agent specifically designed to prevent and treat various thromboembolic events. It functions by selectively inhibiting a key factor in the coagulation cascade, thereby reducing the formation of blood clots without significantly increasing the risk of major bleeding compared to traditional anticoagulants. This targeted mechanism ensures effective prevention of clot formation in both arterial and venous systems. The 120mg dosage is carefully calibrated to provide optimal therapeutic levels, offering consistent protection against thrombotic complications. Clinical trials have demonstrated its superior efficacy and safety profile in high-risk patient populations, making it a valuable option for long-term management. Roarlix is particularly beneficial for patients requiring sustained anticoagulation, providing a predictable pharmacokinetic and pharmacodynamic profile. Regular monitoring for bleeding signs and symptoms is advisable, though routine coagulation tests are often not required.

Uses

• Prevention of stroke in non-valvular atrial fibrillation.
• Treatment of deep vein thrombosis (DVT).
• Prevention of pulmonary embolism (PE).
• Prophylaxis of DVT and PE after orthopedic surgery.

Directions For Use

Take one tablet orally once daily with food, as prescribed by your physician. Swallow the tablet whole; do not crush or chew.

Benefits

• Effectively prevents blood clot formation.
• Reduces risk of stroke and embolism.
• Convenient once-daily dosing.
• Predictable anticoagulant effect.
• Lower risk of major bleeding compared to older agents.
• Does not require routine INR monitoring.

Side Effects

• Minor bleeding (e.g., nosebleeds, bruising)
• Nausea
• Abdominal pain
• Dyspepsia
• Fatigue
• Dizziness
• Headache
• Anemia
• Increased liver enzymes
• Rash
• Hypotension
• Peripheral edema

Safety Measures

• Alcohol - Excessive alcohol consumption may increase the risk of bleeding; use in moderation.
• Pregnancy - Not recommended during pregnancy due to potential fetal harm; alternative treatments should be considered.
• Breastfeeding - Avoid during breastfeeding as the drug may pass into breast milk and pose a risk to the infant.
• Liver - Contraindicated in severe hepatic impairment with coagulopathy; use with caution in mild to moderate impairment.
• Kidney - Dose adjustment is required for moderate to severe renal impairment; not recommended in end-stage renal disease.
• Lung - Generally safe for use in patients with stable lung conditions; monitor for signs of pulmonary hemorrhage.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.